Cargando…
Remdesivir treatment for patients with moderate to severe COVID-19
BACKGROUND/AIM: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treat...
Autores principales: | HASANOĞLU, İmran, GÜNER, Rahmet, ÇELİK, İlhami, KANAT, Fikret, BATIREL, Ayşe, TELLİ DİZMAN, Gülçin, EREN, Esma, YILDIZ SEVGİ, Dilek, BOZKURT, İlkay, KART YAŞAR, Kadriye, ŞENOĞLU, Sevtap, KAZAK, Esra, KARAALİ, Rıdvan, ÇELİKBAŞ, Aysel, PULLUKÇU, Hüsnü, ÇAĞATAY, Arif Atahan, ÜNAL, Serhat, ERDİNÇ, Şebnem, TABAK, Fehmi, GÜL, Ahmet, ALP, Emine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387889/ https://www.ncbi.nlm.nih.gov/pubmed/36326369 http://dx.doi.org/10.55730/1300-0144.5387 |
Ejemplares similares
-
Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020) -
Clinical outcomes of geriatric patients with COVID-19: review of one-year data
por: Ulugerger Avci, Gulru, et al.
Publicado: (2022) -
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
por: Tanriover, Mine Durusu, et al.
Publicado: (2021) -
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020) -
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study
por: Erdal, Gulcin Sahingoz, et al.
Publicado: (2021)